GNTLFGenetic Technologies Ltd.

About Genetic Technologies Ltd. (GNTLF)

Genetic Technologies Ltd. (GNTLF) is a Diagnostics & Research company headquartered in Fitzroy, VA, Australia whose shares trade over-the-counter on the Pink tier.

Genetic Technologies Limited, a molecular diagnostics company, provides predictive genetic testing and risk assessment tools to help physicians manage people's health in the United States, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. It operates in two segments, EasyDNA and GeneType/Corporate. The company offers BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecologists and breast cancer risk assessment specialists, such as breast surgeons. In addition, the company offers various cancer risk assessment tests under the GeneType for Colorectal Cancer and GeneType for Breast Cancer brand names; and develops other risk assessment tests across a range of diseases, which include colorectal cancer, ovarian cancer, prostate cancer, coronary artery, and type 2 diabetes. Further, it offers genetic testing services, including medical, animal, forensic, and plant testing. The company has research and collaboration agreements with the University of Melbourne, Translational Genomics Research Institute, Memorial Sloan Kettering New York Cambridge University, the Ohio State University, and Shivom.

GNTLF key facts

Ticker symbol

GNTLF

Market tier

Pink

Sector

Healthcare

Industry

Diagnostics & Research

Headquarters

Fitzroy, VA, Australia

Country of incorporation

AU

Estimated market cap

$11.54B (as of May 12, 2025)

Shares outstanding

11,541,658,143

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

6/30

Genetic Technologies Ltd. leadership

• Thomas Howitt — CFO

Explore more: Diagnostics & Research stocks · Healthcare sector · Pink stocks · OTC stocks starting with G